无政府主义者 发表于 2025-3-23 10:16:30
Introduction,Chronic myeloid leukemia (CML) is a myeloproliferative disease of the hematopoietic stem cell (HSC). In its natural history, CML is a tri-phasic disease, presenting predominantly in a chronic phase averaging around 5–7 years, but spanning from between a few months to over 20 years.Tdd526 发表于 2025-3-23 15:47:00
Diagnosis,When a patient presents with suspected chronic myeloid leukemia (CML) appropriate assessments are needed to confirm the diagnosis and stage of disease, and to assign a risk score to that patient.人工制品 发表于 2025-3-23 20:52:35
http://reply.papertrans.cn/43/4210/420990/420990_13.png忘恩负义的人 发表于 2025-3-23 22:43:04
http://reply.papertrans.cn/43/4210/420990/420990_14.pngCardioplegia 发表于 2025-3-24 03:15:17
http://reply.papertrans.cn/43/4210/420990/420990_15.png形容词词尾 发表于 2025-3-24 09:51:42
https://doi.org/10.1007/978-3-319-08350-6BCR-ABL signaling; Hematology; Leukemia; Tyrosine kinase inhibitors; pharmacotherapyEVEN 发表于 2025-3-24 10:40:19
http://reply.papertrans.cn/43/4210/420990/420990_17.png宪法没有 发表于 2025-3-24 15:42:42
http://reply.papertrans.cn/43/4210/420990/420990_18.pngForsake 发表于 2025-3-24 19:49:40
http://reply.papertrans.cn/43/4210/420990/420990_19.png憎恶 发表于 2025-3-25 00:37:59
https://doi.org/10.1007/978-3-030-01294-6 not. Palliation with alpha interferon (IFNα) could prolong survival substantially for the 15–30 % of patients who had IFNα-responsive disease but quality of life for these patients was often markedly impaired.